Phytases, nucleic acids encoding them and methods for making and using them
View Patent ↗This invention relates to phytases, polynucleotides encoding them, uses of the polynucleotides and polypeptides of the invention, as well as the production and isolation of such polynucleotides and polypeptides. In particular, the invention provides polypeptides having phytase activity under high temperature conditions, and phytases that retain activity after exposure to high temperatures. The phytases of the invention can be thermotolerant and/or thermostable at low temperatures, in addition to higher temperatures. The phytases of the invention can be used in foodstuffs to improve the feeding value of phytate rich ingredients. The phytases of the invention can be formulated as foods or feeds or supplements for either to, e.g., aid in the digestion of phytate. The foods or feeds of the invention can be in the form of pellets, liquids, powders and the like. In one aspect, phytases of the invention are stabile against thermal denaturation during pelleting; and this decreases the cost of the phytase product while maintaining in vivo efficacy and detection of activity in feed.
1. A variant polypeptide comprising an amino acid sequence that is at least 90% identical to the amino acid sequence of SEQ ID NO: 2, wherein the amino acid sequence of the variant polypeptide comprises an amino acid substitution selected from the group consisting of: C97E, C97V, E168E, and C226D; and further includes at least one additional amino acid substitution selected from the group consisting of: A47F, T136F, N159V, N159E, T163R, D164R, G179R, V233W, Q275V, R289A, and T349Y, and wherein said variant polypeptide has phytase activity.
2. A protein preparation comprising the variant polypeptide as set forth in claim 1 , wherein the protein preparation comprises a liquid, a slurry, a powder, a spray, a suspension, a lyophilized composition/formulation, a solid, geltab, pill, implant, a gel; or a pharmaceutical formulation, a food or a feed or a supplement thereof.
3. A food or feed, or a food or feed supplement, for an animal or a human comprising the variant polypeptide as set forth in claim 1 ; wherein said food or feed, or a food or feed supplement is in a pellet, pill, tablet, capsule, geltab, spray, powder, slurry, suspension or liquid form, or produced using polymer-coated additives, or manufactured in granulate form, or produced by spray drying.
4. An edible or absorbable enzyme delivery matrix comprising the variant polypeptide as set forth in claim 1 ; wherein said edible or absorbable enzyme delivery matrix is in the form of, a pellet, pill, tablet, capsule, geltab, spray, powder, slurry, suspension, or liquid form, or produced using polymer-coated additives, or manufactured in granulate form, or produced by spray drying.
5. A self-contained meal Ready-to-Eat unit (MRE), a drink, a hydrating agent, a chewable tablet, a nutritional bar, or a baked good comprising the variant polypeptide as set forth in claim 1 .
6. The variant polypeptide as set forth in claim 1 ; wherein the variant polypeptide is glycosylated, or the variant polypeptide comprises at least one glycosylation site, wherein optionally said variant polypeptide is glycosylated after being expressed in a yeast cell; wherein optionally the yeast cell is a Pichia pastoris or a Schizoscaccharomyces pombe.
7. The variant polypeptide as set forth in claim 1 ; wherein the variant polypeptide is lacking a signal sequence, a leader sequence, or a leader peptide.